CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Kettering, Ohio, United States and 92 other locations
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Cincinnati, Ohio, United States and 107 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Cincinnati, Ohio, United States and 72 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Cincinnati, Ohio, United States of America and 50 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Cincinnati, Ohio, United States of America and 29 other locations
of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...
Cincinnati, Ohio, United States of America and 32 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Cincinnati, Ohio, United States and 388 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Cincinnati, Ohio, United States and 233 other locations
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...
Phase 3
Cincinnati, Ohio, United States and 68 other locations
This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling tim...
Phase 3
Centerville, Ohio, United States and 68 other locations
Clinical trials
Research sites
Resources
Legal